Loading...
XSHG603168
Market cap342mUSD
Jan 02, Last price  
6.76CNY
1D
0.90%
1Q
-11.98%
Jan 2017
-70.80%
IPO
-68.25%
Name

Zhejiang Shapuaisi Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XSHG:603168 chart
P/E
98.25
P/S
3.87
EPS
0.07
Div Yield, %
0.55%
Shrs. gr., 5y
2.28%
Rev. gr., 5y
1.21%
Revenues
645m
+17.37%
146,515,602174,535,451272,552,318408,681,421544,757,635628,140,667765,582,438921,670,916978,732,133938,883,499607,437,969515,957,073358,231,310629,764,709549,536,975644,970,190
Net income
25m
-43.23%
18,056,89419,084,43143,095,15967,912,69590,885,942104,082,434131,269,854176,036,262275,717,381146,356,42007,857,251035,656,09344,751,60925,407,600
CFO
41m
-64.14%
11,197,84028,871,02817,565,04115,143,18767,268,343117,860,928147,991,883114,273,314294,331,01545,572,205100,373,49559,469,24744,090,367100,782,133115,721,49341,493,448
Dividend
Jun 13, 20240.021 CNY/sh
Earnings
May 15, 2025

Profile

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products. The company provides its products to ophthalmology, antipyretic and analgesic, antibacterial anti-inflammatory, endocrine, auxiliary, cardiovascular, detoxification, diuretic row stone, gynecology, and infusion categories. It offers its products in injections, oral solutions, eye drops, tablets, capsules, and other dosage forms. Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. was founded in 1978 and is based in Pinghu, China.
URL
http://www.zjspas.com/
IPO date
Jul 02, 2014
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
644,970
17.37%
549,537
-12.74%
Cost of revenue
578,993
457,702
Unusual Expense (Income)
NOPBT
65,977
91,835
NOPBT Margin
10.23%
16.71%
Operating Taxes
7,974
9,260
Tax Rate
12.09%
10.08%
NOPAT
58,003
82,575
Net income
25,408
-43.23%
44,752
25.51%
Dividends
(13,767)
Dividend yield
0.28%
Proceeds from repurchase of equity
(2,120)
BB yield
0.07%
Debt
Debt current
85,982
5,932
Long-term debt
104,432
67,511
Deferred revenue
2,473
Other long-term liabilities
1
Net debt
(410,932)
(520,663)
Cash flow
Cash from operating activities
41,493
115,721
CAPEX
(219,795)
Cash from investing activities
(345,892)
Cash from financing activities
135,007
315,260
FCF
(86,077)
(55,754)
Balance
Cash
369,201
554,331
Long term investments
232,145
39,774
Excess cash
569,097
566,629
Stockholders' equity
732,162
827,735
Invested Capital
1,319,484
1,182,448
ROIC
4.64%
7.29%
ROCE
3.49%
5.25%
EV
Common stock shares outstanding
362,966
328,122
Price
13.41
47.04%
9.12
-3.80%
Market cap
4,867,370
62.65%
2,992,474
-2.15%
EV
4,466,136
2,481,812
EBITDA
140,926
157,664
EV/EBITDA
31.69
15.74
Interest
2,603
1,643
Interest/NOPBT
3.95%
1.79%